[1] 中华人民共和国卫生部药品标准中药成方制剂.第十七册[S].1998:205 Drug Specifications for Traditional Chinese Medicine Preparations by the Ministry of Public Health,P.R. China.Part 17[S].1998:205
[2] 林晓艺,陈志桃.骨松宝颗粒质量标准研究[J].海峡药学,2007,19(8):39 LIN XY,CHEN ZT.Studies on the quality standard of Gusongbao granules[J].Strait Pharm J,2007,19(8):39
[3] 张志锋,刘忠荣,及元乔,等.HPLC测定骨松宝颗粒中淫羊藿苷的含量[J].华西药学杂志,2005,20(4):351 ZHANG ZF,LIU ZR,JI YQ,et al.Determination of icariin content in Gusongbao granules by HPLC[J].West China J Pharm Sci,2005,20(4):351
[4] 周兰.反向高效液相色谱法测定骨松宝颗粒中淫羊藿苷的含量[J].药物分析杂志,1998,18(增刊):162 ZHOU L.Determination of icariin content in Gusongbao granules by RP-HPLC[J].Chin J Pharm Anal,1998,18(Suppl):162
[5] 穆建国,甘惠仍,贾宪生.HPLC测定骨松宝颗粒中淫羊藿苷和朝藿定C的含量[J].中国执业药师,2014,11(6):27 MU JG,GAN HR,JIA XS.Content determination of icariin and epimedin C in Gusongbao granules by HPLC[J].Chin Lic Pharm,2014,11(6):27
[6] 张明昶,刘毅.一阶导数光谱法测定骨松宝颗粒中淫羊藿苷类化合物的含量[J].贵阳中医学院学报,2002,24(4):56 ZHANG MC,LIU Y.Determination of icariin analogues in Gusongbao granule by first order derivative spectrophotometry[J].J Guiyang Coll Tradit Chin Med,2002,24(4):56
[7] 秦伟瀚,刘翔,张军,等.不同产地15个品种淫羊藿的质量评价[J].中成药,2017,39(9):1889 QIN WH,LIU X,ZHANG J,et al.Quality evaluation of fifteen varieties of Epimedii Folium from different growing areas[J].Chin Tradit Pat Med,2017,39(9):1889
[8] 张顺聪,郭丹青,李永贤,等.淫羊藿苷对人成骨样细胞分化及OPG/RANKL表达的影响[J].中国骨质疏松杂志,2016,22(4):433 ZHANG SC,GUO DQ,LI YX,et al.Effects of icariin on the differentiation of osteoblast and regulation of the OPG-RANKL system in MG-63 cells[J].Chin J Osteoporos,2016,22(4):433
[9] 邓君,邱波.淫羊藿苷对骨质疏松性老年骨折模型愈合过程的影响[J].中国老年学杂志,2018,38(5):1187 DENG J,QIU B.Effect of icariin on healing process of senile osteoporotic fracture models[J].Chin J Geront,2018,38(5):1187
[10] 肖亚平,曾杰,焦琳娜,等.补肾中药对骨质疏松症的治疗及其信号通路调节作用的研究进展[J].中国中药杂志,2018,43(1):21 XIAO YP,ZENG J,JIAO LN,et al.Review for treatment effect and signaling pathway regulation of kidney-tonifying traditional Chinese medicine on osteoporosis[J].China J Chin Mater Med,2018,43(1):21
[11] 孙晨瑜,谢国勇,秦民坚.芒果苷在植物界的分布及药理活性研究进展[J].中国野生植物资源,2017,36(4):39 SUN CY,XIE GY,QIN MJ.Distribution of mangiferin in plant kingdom and its pharmacological research progress[J].Chin Wild Plant Resour,2017,36(4):39
[12] 杨海光,方莲花,杜冠华.芒果苷的药理作用研究进展[J].中国药理学通报,2016,32(1):5 YANG HG,FANG LH,DU GH.Research progress of pharmacological effects of mangiferin[J].Chin Pharmacol Bull,2016,32(1):5
[13] 王常顺,刘永利,段吉平,等.双波长-UPLC法同时测定知柏地黄丸中6个成分的含量[J].药物分析杂志,2018,38(2):256 WANG CS,LIU YL,DUAN JP,et al.Simultaneous quantification of six components in Zhibai Dihuang pills by dual-wavelength UPLC[J].Chin J Pharm Anal,2018,38(2):256
[14] 王化,何丹饶,朱良玉,等.HPLC法同时测定赤芍中9个活性成分的含量[J].中草药,2018,49(3):708 WANG H,HE DR,ZHU LY,et al.Simultaneous determination of nine components in Paeoniae Radix Rubra by HPLC[J].Chin Tradit Herb Drugs,2018,49(3):708
[15] 吴修红,孙晓兰,胡妮娜,等.赤芍功效物质基础研究进展[J].中医药信息,2017,34(2):120 WU XH,SUN XL,HU NN,et al.Progress on the material basis of efficacy of Radix Paeoniae Alba[J].Inf Tradit Chin Med,2017,34(2):120
[16] 吴丽,王丽丽,费文婷,等.芍药苷和芍药内酯苷对小鼠疼痛模型的镇痛作用及β-EP、PEG2的影响[J].中华中医药杂志,2018,33(3):915 WU L,WANG LL,FEI WT,et al.Analgesic effect of paeoniflorin and albiflorin on acetic acid induced writhing mice and the expression of β-EP and PGE2[J].Chin J Tradit Chin Med Pharm,2018,33(3):915
[17] 李丹,李彦文,王俊文,等.基于文献计量分析川芎有效成分药理作用研究[J].世界中医药,2017,12(5):1161 LI D,LI YW,WANG JW,et al.Research on pharmacological action of active ingredients of Ligusticum wallichii based on bibliometrics[J].World Chin Med,2017,12(5):1161
[18] 李洋,季芳茹,潘洪秀,等.HPLC法同时测定不同配伍比例三棱-莪术药对中p-香豆酸、阿魏酸的含量[J].中国药房,2017,28(27):3859 LI Y,JI FR,PAN HX,et al.Simultaneous determination of P-coumaric acid and ferulic acid in different compatibility proportions of the couple of Sparganium stoloni and Curcuma aeruginosa by HPLC[J].China Pharm,2017,28(27):3859
[19] CHENG C,HO T,LEE E,et al.Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats[J].Am J Chin Med,2008,36(6):1105
[20] 田欢,赵锋,李晔,等.川续断皂苷Ⅵ的研究进展[J].中国实验方剂学杂志,2018,24(5):226 TIAN H,ZHAO F,LI Y,et al.Research progress of asperosaponin Ⅵ[J].Chin J Exp Tradit Med Form,2018,24(5):226
[21] 中华人民共和国药典2015年版.一部[S].2015:40,158,212,327,329 ChP 2015.Vol Ⅰ[S].2015:40,158,212,327,329